HSP90B1 and neoplasm: Furthermore, inhibition of Grp94 by ganetespib significantly augmented nebivolol-mediated both reduction of EGFRL858R/T790M expression and inhibition of tumor growth (Fig. 6o and Supplementary Fig. 9c−h).